sr141716 has been researched along with desacetylnantradol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Houston, DB; Howlett, AC | 1 |
Gafni, M; Rubovitch, V; Sarne, Y | 1 |
2 other study(ies) available for sr141716 and desacetylnantradol
Article | Year |
---|---|
Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists.
Topics: Animals; Benzoxazines; Binding Sites; Binding, Competitive; Brain; Cannabinoids; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Morpholines; Naphthalenes; Phenanthridines; Piperidines; Pyrazoles; Radioligand Assay; Rats; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Sodium | 1998 |
The cannabinoid agonist DALN positively modulates L-type voltage-dependent calcium-channels in N18TG2 neuroblastoma cells.
Topics: Adenylyl Cyclases; Analgesics; Animals; Calcium; Calcium Channels, L-Type; Calcium Signaling; Calmodulin; Cannabinoids; Central Nervous System; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Membrane Potentials; Neuroblastoma; Pertussis Toxin; Phenanthridines; Piperidines; Protein Kinase C; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Sodium Channels; Tumor Cells, Cultured; Virulence Factors, Bordetella | 2002 |